These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22672816)

  • 21. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support).
    Nyberg SL; Shatford RA; Hu WS; Payne WD; Cerra FB
    Crit Care Med; 1992 Aug; 20(8):1157-68. PubMed ID: 1643896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioartificial liver support.
    Bain VG; Montero JL; de La Mata M
    Can J Gastroenterol; 2001 May; 15(5):313-8. PubMed ID: 11381299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a rotary bioartificial liver in the differentiation of human liver stem cells.
    Fonsato V; Herrera MB; Buttiglieri S; Gatti S; Camussi G; Tetta C
    Tissue Eng Part C Methods; 2010 Feb; 16(1):123-32. PubMed ID: 19397473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
    Kobayashi N; Okitsu T; Nakaji S; Tanaka N
    J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The therapeutic effect and difficulty in clinic application of bioartificial liver].
    XIN SJ; LIU HL
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):328-9. PubMed ID: 19497193
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in cell sources of hepatocytes for bioartificial liver.
    Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments in bioartificial liver research: concepts, performance, and applications.
    Nagamori S; Hasumura S; Matsuura T; Aizaki H; Kawada M
    J Gastroenterol; 2000; 35(7):493-503. PubMed ID: 10905356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioartificial liver support.
    Hui T; Rozga J; Demetriou AA
    J Hepatobiliary Pancreat Surg; 2001; 8(1):1-15. PubMed ID: 11294283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioartificial liver support: developments in hepatocyte culture and bioreactor design.
    Riordan S; Williams R
    Br Med Bull; 1997; 53(4):730-44. PubMed ID: 9536524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioartificial liver systems: current status and future perspective.
    Park JK; Lee DH
    J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioartificial liver devices: Perspectives on the state of the art.
    Ding YT; Shi XL
    Front Med; 2011 Mar; 5(1):15-9. PubMed ID: 21088931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems and prospects of creation of extracorporal systems for support of functional livers status].
    Ryabinin VE
    Biomed Khim; 2015; 61(5):545-59. PubMed ID: 26539863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of bioartificial liver support systems.
    van de Kerkhove MP; Hoekstra R; Chamuleau RA; van Gulik TM
    Ann Surg; 2004 Aug; 240(2):216-30. PubMed ID: 15273544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.
    Naruse K; Tang W; Makuuch M
    World J Gastroenterol; 2007 Mar; 13(10):1516-21. PubMed ID: 17461442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A promising hepatocyte-like cell line, CCL-13, exhibits good liver function both in vitro and in an acute liver failure model.
    Yang T; Li C; Zhang L; Li M; Zhou P
    Transplant Proc; 2013 Mar; 45(2):688-94. PubMed ID: 23498808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Plomer G; Seppen J; Ackermans MT; Camus S; Kulik W; van Gulik TM; Elferink RP; Chamuleau RA
    Drug Metab Dispos; 2013 Mar; 41(3):562-7. PubMed ID: 23238784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices.
    Liu J; Jauregui HO; Faris RA; Santangini HA; Trenkler DM; Silva PG; Garcia KM
    Artif Organs; 2001 Jul; 25(7):539-45. PubMed ID: 11493274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.
    Nyberg SL; Shirabe K; Peshwa MV; Sielaff TD; Crotty PL; Mann HJ; Remmel RP; Payne WD; Hu WS; Cerra FB
    Cell Transplant; 1993; 2(6):441-52. PubMed ID: 8167929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel bioartificial liver containing small tissue fragments: efficiency in the treatment of acute hepatic failure induced by carbon tetrachloride in rats.
    Soloviev V; Hassan AN; Akatov V; Lezhnev E; Ghaffar TY; Ghaffar YA
    Int J Artif Organs; 2003 Aug; 26(8):735-42. PubMed ID: 14521171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.